Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease (ETON-Study)

NCT01357681 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Huntington Disease

Interventions

DRUG: (2)-epigallocatechin-3-gallate (EGCG)
DRUG: Placebo

Sponsor

Charite University, Berlin, Germany